Cardiac Amyloidosis

Cardiac amyloidosis is a myocardial disease characterized by extracellular amyloid infiltration throughout the heart. Discover the latest research on cardiac amyloidosis here.

September 11, 2020

Focal myocardial perfusion abnormalities in cardiac amyloidosis as compared with CMR, bone scintigraphy, and 11 C-PiB PET

Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology
Toshiya EnsakoYoshihiro Nishiyama
September 6, 2020

Absolute Quantitation of Cardiac 99m Tc-pyrophophate Using Cadmium Zinc Telluride-based SPECT/CT

Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
Sharmila DorbalaMarcelo F Di Carli
August 25, 2020
Open Access

Repurposing of existing FDA approved drugs for Neprilysin inhibition: An in-silico study

Journal of Molecular Structure
Runali SankheAnoop Kishore
September 18, 2020
Case Report

Coronary revascularisation in cardiac amyloidosis

Journal of Cardiac Surgery
Alexander SmithShirish Ambekar
August 28, 2020
Open Access

Gastric AA amyloidosis secondary to chronic infection presenting with hematemesis: a case report

Clinical Journal of Gastroenterology
Yuting HuangShien Hu
September 16, 2020
Review

Systemic amyloidosis from A (AA) to T (ATTR): a review

Journal of Internal Medicine
E MuchtarM A Gertz
August 25, 2020
Open Access

JCS 2020 Guideline on Diagnosis and Treatment of Cardiac Amyloidosis

Circulation Journal : Official Journal of the Japanese Circulation Society
Hiroaki KitaokaJapanese Circulation Society Joint Working Group
September 13, 2020

Inter-observer reproducibility and intra-observer repeatability in 99m Tc-pyrophosphate scan interpretation for diagnosis of transthyretin cardiac amyloidosis

Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology
Vasvi SinghSharmila Dorbala
September 9, 2020

Red flags in patients with hereditary transthyretin amyloidosis at diagnosis in a non-endemic area of Spain

Neurología : publicación oficial de la Sociedad Española de Neurología
L Silva-HernándezL Galán Dávila
September 2, 2020
Open Access

Survival Following Implantable Cardioverter-Defibrillator Implantation in Patients With Amyloid Cardiomyopathy

Journal of the American Heart Association
Angela Y HigginsJames V Freeman
September 15, 2020

Ameliorative effects of pregabalin on LPS induced endothelial and cardiac toxicity

Biotechnic & Histochemistry : Official Publication of the Biological Stain Commission
H AsciN Hasseyid
August 22, 2020
Comment / Editorial

An Orphan Disease No More: Additional Treatment Options for Cardiac Amyloidosis

Journal of Cardiac Failure
Nitasha Sarswat
September 10, 2020

Advanced Nuclear Medicine and Molecular Imaging in the Diagnosis of Cardiomyopathy

AJR. American Journal of Roentgenology
Ming YangMichael C Roarke
September 5, 2020
Review
Open Access

Systemic AL Amyloidosis: Current Approaches to Diagnosis and Management

HemaSphere
Despina FotiouEfstathios Kastritis

Sign up to follow this feed and discover related papers.

Related Feeds

22q11 Deletion Syndrome

22q11.2 deletion syndrome, also known as DiGeorge syndrome, is a congenital disorder caused as a result of a partial deletion of chromosome 22. Here is the latest research.

Alagille Syndrome

Alagille syndrome is a multi-system genetic disorder that can affect the liver, heart, and other parts of the body. It’s characterization includes heart problems, liver damage, jaundice, and xanthomas. Here is the latest research.

Aneurysm

Aneurysms are outward distensions or bulges that occurs in a weakened wall of blood vessels. Discover the latest research on aneurysms here.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Aortic Aneurysm

An aortic aneurysm is the weakening and bulging of the blood vessel wall in the aorta. This causes dilatation of the aorta, which is usually asymptomatic but carries the risk of rupture and hemorrhage. Find the latest research on aortic aneurysms here.

Aortic Coarctation

Aortic coarctation is a congenital condition characterized by narrowing of the aorta. Discover the latest research on this disease here.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Arrhythmogenic Right Ventricular Dysplasia

Arrhythmogenic right ventricular dysplasia is a congenital cardiomyopathy that is characterized by infiltration of adipose and fibrous tissue into the right ventricle wall and loss of myocardial cells. Primary injuries usually are at the free wall of the right ventricular and right atria resulting in ventricular and supraventricular arrhythmias. Discover the latest research on arrhythmogenic right ventricular dysplasia here.

© 2020 Meta ULC. All rights reserved
/feed-previews/cardiac-amyloidosis/08398671-d2fb-456d-bcd6-7cf5393c7e0b